Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Unicycive Therapeutics, Inc. (UNCY) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-26.55M |
|
-- |
|
-- |
|
$29.52M |
|
$-29.52M |
|
$2.96M |
|
$-26.55M |
|
$-26.55M |
|
$-26.55M |
|
$-26.55M |
|
$-26.55M |
|
$-26.55M |
|
$-29.52M |
|
$-28.95M |
|
15.89M |
|
15.89M |
|
$-1.67 |
|
$-1.67 |
|
| Balance Sheet Financials | |
$48.96M |
|
$0.07M |
|
$0.17M |
|
$49.13M |
|
$18.94M |
|
-- |
|
-- |
|
$18.94M |
|
$30.20M |
|
$30.20M |
|
$30.20M |
|
22.11M |
|
| Cash Flow Statement Financials | |
$-31.32M |
|
$-12.10M |
|
$46.47M |
|
$26.14M |
|
$29.20M |
|
$3.06M |
|
$2.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.59 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-31.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-87.94% |
|
-87.94% |
|
-54.05% |
|
-87.94% |
|
$1.37 |
|
$-1.97 |
|
$-1.97 |
|